1 / 7

Candidiasis Market to See Booming Growth 2023-2030

Candidiasis is a type of infection caused due to the yeast u2013 candida, also classified as fungus, which is present in the human body. It is usually present in places such as mouth, belly, and on the skin. This dormant yeast can lead to candida infection at any stage in a personu2019s life and is closely linked to the immunity level of the person.<br>Click Link: https://www.coherentmarketinsights.com/insight/request-sample/229

Saya10
Download Presentation

Candidiasis Market to See Booming Growth 2023-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Candidiasis Market 2023 CAGR 4.6% Market Size 2023 US$ 873.8 million 2030Value Projection US$ 1,307.2 Million

  2. Global Candidiasis Market Definition • Candidiasis is a type of infection caused due to the yeast – candida, also classified as fungus, which is present in the human body. It is usually present in places such as mouth, belly, and on the skin. This dormant yeast can lead to candida infection at any stage in a person’s life and is closely linked to the immunity level of the person. There are various types of infections caused due to candidiasis such as thrush/ oropharyngeal candidiasis, genital yeast infection/ invasive infection, and cutaneous candidiasis. • Candidiasis is treated using various treatment options such as oral medication, injection, and ointments. The condition is usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines. Increasing consumer awareness about candidiasis and growing number of treatment options are major factors that are fueling growth of the candidiasis market.

  3. Segments covered: By Drug Class By Distribution Channel By Type Candida infections of the mouth, throat, and esophagus Vaginal candidiasis Invasive/systemic candidiasis Azoles Echinocandins Polyenes Flucytosine Hospital Pharmacies Retail Pharmacies Online Pharmacies

  4. Candidiasis Market Competitive Analysis • BasileaPharmaceutica Ltd • AstellasPharma Inc. • Grupo Ferrer Internacional, S.A. • Pacgen Life Science Corporation • NovaDigm Therapeutics, Inc. • Cidara Therapeutics, Inc. • Amplyx Pharmaceuticals Inc. • Pfizer, Inc.

  5. Candidiasis Market– Growth Drivers, Restraints & Challenges Growth Drivers Restraints & Challenges Antifungal Resistance Limited Treatment Options Diagnostic Challenges • Increasing Prevalence of Candidiasis • Rising Awareness and Diagnosis • Technological Advancements in Diagnostics

  6. Key Features Of The Study: • This report provides in-depth analysis of the global candidiasis market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global candidiasis market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • The global candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

  7. CONTACT US

More Related